General Provider COVID-19 Resources and Information
Information for all healthcare organizations and physicians in the State as well as their partners to help ensure all those involved have correct and up-to-date information about this outbreak.
Calls with Healthcare and Public Health Partners
Calls with Healthcare and Public Health Partners
Next webinar will be Thursday, December 8th from 12-1 pm
Recurring calls are scheduled for 2nd Thursday of each month from 12 - 1 PM
Please click the link below to join the webinar:
US: +1 646 558 8656 or +1 301 715 8592 or +1 312 626 6799 or +1 669 900 9128 or +1 253 215 8782 or +1 346 248 7799
Webinar ID: 940 5928 7404
How to Become a COVID-19 Vaccine Provider
As COVID-19 vaccine is available for all eligible individuals, NH DHHS will distribute COVID-19 vaccines to provider offices, urgent care, pharmacies and other local health care facilities that have the capacity to offer vaccination to patients. To receive/administer COVID-19 vaccine, constituent products, and ancillary supplies, health care organizations that want to receive COVID-19 vaccine must enroll in the federal COVID-19 Vaccination Program coordinated through the New Hampshire Immunization Program. Enrolled COVID-19 vaccination providers must be credentialed/licensed in the jurisdiction where vaccination takes place and sign and agree to the conditions in the CDC COVID-19 Vaccination Program Provider Agreements. These conditions are detailed in the agreement itself. Note that NH DHHS will only be able to begin providing vaccine to these entities when vaccine supply allows.
In order to enroll as a COVID-19 vaccination provider, download the Provider Agreement complete the form electronically, being careful to follow the instructions, and email to C19Enrollment@dhhs.nh.gov.
- Provider Agreement Instructions
- Provider Agreement (must be downloaded and opened in Adobe Acrobat, not completed in the web browser)
COVID-19 Rapid / Point of Care Test Reporting Guidance
This guidance is intended to provide authorized facilities administering rapid or point of care COVID-19 tests (e.g. antigen and nucleic acid amplification tests) with instructions for reporting individual level test results to the Department of Health and Human Services, Division of Public Health Services. As of April 4, 2022:
- All Nucleic Acid Amplification Test (NAAT) results (positive, negative, inconclusive, etc.) which are performed in a facility certified by CLIA must continue to be reported
- Only positive antigen (or other rapid non-NAAT) test results must be reported from providers and testing locations operating under a CLIA certificate; negative antigen tests do NOT need to be reported
- At-home or self-administered tests do NOT need to be reported
- Antibody test results do NOT need to be reported
When reporting results, please provide information for all fields for which you have information. For technical assistance, contact the Public Health COVID-19 Operations Center at 603-271-6996, Monday through Friday between 8:00am and 4:30pm.
- NH Science Brief: Safety and Effectiveness of COVID-19 mRNA Vaccines in Adults, Adolescents, & Children (September 2022)
- Isolation & Quarantine Information
- COVID-19 Positive Case Reporting Form
- Letter to Providers Concerning COVID-19 Testing and Exclusion (August 11, 2021)
- Providers should familiarize themselves with the developing COVID-19 outbreak and review the CDC website.
- Environmental Cleaning and Disinfection Recommendations
- Medicaid COVID-19 Providers Guidance
Preventative Care During COVID-19
Mental Health Guidance
Community Health Workers (CHW) Resources
NH Health Alert Network (HAN) Messages
The New Hampshire Public Health Laboratories (PHL) now has testing capacity for COVID-19. Results take a minimum of 24 hours from receipt of clinical specimens.
To submit specimens to the NH PHL for COVID-19 testing, the guidance below for "Laboratory Testing for COVID-19" should be followed, including completion of the NH PHL Requisition.
For specimens being sent to New Hampshire Public Health Lab: Collect NP swabs and place into tube of viral transport media (VTM). Read the COVID-19 Specimen Collection And Transport Kit Instructions.
- CDC Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons Under Investigation (PUIs) for Coronavirus Disease 2019 (COVID-19)
Resources for Healthcare Providers
- Moderna COVID-19 Vaccine Storage & Handling
- Pfizer-BioNTech COVID-19 Vaccine Handling and Administration
- Janssen (J&J) COVID-19 Vaccine Storage, Dosage and Administration (April 27, 2021)
- CDC's COVID-19 Vaccination Communication Toolkit for Medical Centers, Clinics, and Clinicians
- CDC COVID-19 Information for Healthcare Professionals and Jurisdictions
- CDC COVID-19 Vaccine Training Module: General Overview of Immunization Best Practices for Healthcare Professionals